Agenus shared a post on LinkedIn:
“Agenus will host its first Stakeholder Webcast of 2026 tomorrow, Wednesday, January 28 at 4:00 p.m. ET.
This live session will bring together Agenus leadership and international oncology leaders to discuss:
- The momentum driving global access to BOT+BAL for eligible patients
- Clinical development and strategic partnerships updates
- Ensuring operational readiness for increased interest
Featured Speakers:
- Dr. Robin Jones: The Royal Marsden London, UK
- Dr. José Iglesias: Chief Medical Affairs Officer, Agenus
- Dr. Garo Armen: Founder, Chairman, and CEO, Agenus
The event will conclude with a live Q&A.
Submit questions in advance to: ask@agenusbio.com”